TRAX TRAX Unrealized gains (losses) on available-for-sale securities

Unrealized gains (losses) on available-for-sale securities at other companies

Rhythm Pharmaceuticals, Inc.RYTM

-$544K-5,340%

Jackson FinancialJXN

-$552M-191%

Ford Motor CompanyF

-$69M-203%

Construction PartnersROAD

-$158K-168%

ArganAGX

-$2.66M-199%

CytokineticsCYTK

-$1.84M-240%

Operating income-$52.8M-3.0%

Net income-$50.5M-7.0%

Cash & equivalents$248.5M—

Total debt$14.1M—

Total equity$257.5M-28.0%

Total assets$290.6M—

Operating cash flow-$32.6M+27.7%

CapEx$17.0K-51.4%

Free cash flow-$32.6M+27.7%

Market cap$0—

Current ratio8.7×—

Reported directly by TRAX in its filing.

Tagged under the XBRL concept us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax.

The official record: TRAX’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Connect your AI assistant and compare it to peers, right in your chat.

What is TRAX's unrealized gains (losses) on available-for-sale securities?: TRAX (TRAX) reported unrealized gains (losses) on available-for-sale securities of -$122K in Q1 2026.